New Human Tumor Biomarker Performance Luminex Panel
Prepare to revolutionize your cancer research with our new Human Tumor Biomarker Luminex Panel, set to launch soon. This panel, compromised of 28 tumor biomarkers, provides an abundance of data for many cancer types, such as prostate, colorectal, and lung cancer. Sign up below to be the first to know when this panel is available or if interested in our exclusive beta testing program.
- Customizable tumor panel of up to 28 tumor biomarkers with only 50 uL of sample
- Validated for use with serum, plasma (including Streck plasma), cell culture supernates, cell lysates, and tissue lysates
- Get results quickly with 3.5-hour assay time
Analytes Available:
AFP
CA15-3
CA125
CA19-9
CD40 Ligand/TNFSF5
CEACAM-5
CG beta (HCG beta)
Chromogranin A (CHGA)
CYFRA21-1
Fas
Fas Ligand
FGF basic
Glypican-1
HGF
HE4/WFDC2
IL-6
IL-8/CXCL8
Leptin
MIF
Neuron-specific enolase (NSE)
Osteopontin/OPN
PSA Total
Prolactin
SCF/c-kit Ligand
TGF-alpha
Thyroglobulin
TNF-alpha
VEGF
Cancer Sample Data:
Pancreatic and colorectal cancer serum samples were tested alongside healthy controls on the Human Tumor Biomarker Panel and significant differences were observed over many analytes. A selection of these are shown below.
Luminex® is a Registered Trademark of Luminex Corporation.